ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Compass Therapeutics Inc

Compass Therapeutics Inc (CMPX)

1.695
0.045
(2.73%)
마감 13 4월 5:00AM
1.62
-0.075
(-4.42%)
시간외 거래: 7:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
1.62
매수가
1.68
매도가
1.77
거래량
650,760
1.61 일간 변동폭 1.70
0.765 52주 범위 4.08
market_cap
전일 종가
1.65
개장가
1.63
최근 거래 시간
1
@
1.68
마지막 거래 시간
재정 규모
US$ 1,074,336
VWAP
1.6509
평균 볼륨(3m)
1,709,116
발행 주식
138,282,498
배당수익률
-
주가수익률
-4.73
주당순이익(EPS)
-0.36
매출
850k
순이익
-49.38M

Compass Therapeutics Inc 정보

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engi... Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
본부
Wilmington, Delaware, USA
설립됨
-
Compass Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CMPX. The last closing price for Compass Therapeutics was US$1.65. Over the last year, Compass Therapeutics shares have traded in a share price range of US$ 0.765 to US$ 4.08.

Compass Therapeutics currently has 138,282,498 shares in issue. The market capitalisation of Compass Therapeutics is US$228.17 million. Compass Therapeutics has a price to earnings ratio (PE ratio) of -4.73.

Compass Therapeutics (CMPX) 옵션 플로우 요약

전체 흐름

약세

순 프리미엄

-725k

Calls / Puts

0.00%

매수 / 매도

0.00%

OTM / ITM

0.00%

Sweeps 비율

0.00%

CMPX 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1001.621.91.4129128561.68050772CS
4-0.94-36.718752.562.6651.3328356712.01054194CS
12-0.87-34.93975903612.494.081.3317091162.45688527CS
26-0.1-5.813953488371.724.081.2713198562.19638473CS
520.074.516129032261.554.080.7658391302.01358135CS
1560.149.459459459461.485.650.7655034692.3174124CS
260-2.48-60.4878048784.15.650.7654377182.3348162CS

CMPX - Frequently Asked Questions (FAQ)

What is the current Compass Therapeutics share price?
The current share price of Compass Therapeutics is US$ 1.62
How many Compass Therapeutics shares are in issue?
Compass Therapeutics has 138,282,498 shares in issue
What is the market cap of Compass Therapeutics?
The market capitalisation of Compass Therapeutics is USD 228.17M
What is the 1 year trading range for Compass Therapeutics share price?
Compass Therapeutics has traded in the range of US$ 0.765 to US$ 4.08 during the past year
What is the PE ratio of Compass Therapeutics?
The price to earnings ratio of Compass Therapeutics is -4.73
What is the cash to sales ratio of Compass Therapeutics?
The cash to sales ratio of Compass Therapeutics is 277.05
What is the reporting currency for Compass Therapeutics?
Compass Therapeutics reports financial results in USD
What is the latest annual turnover for Compass Therapeutics?
The latest annual turnover of Compass Therapeutics is USD 850k
What is the latest annual profit for Compass Therapeutics?
The latest annual profit of Compass Therapeutics is USD -49.38M
What is the registered address of Compass Therapeutics?
The registered address for Compass Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Compass Therapeutics website address?
The website address for Compass Therapeutics is www.compasstherapeutics.com
Which industry sector does Compass Therapeutics operate in?
Compass Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MSPRMSP Recovery Inc
US$ 2.479
(93.67%)
85.68M
PRTGPortage Biotech Inc
US$ 8.5091
(66.85%)
29.09M
WTOUTime Limited
US$ 2.15
(61.65%)
1.19M
BFRGBullfrog AI Holdings Inc
US$ 2.09
(48.23%)
13.75M
THTXTheratechnologies Inc
US$ 1.94
(45.86%)
48.09M
MBMasterBeef Group
US$ 3.30
(-90.95%)
2.46M
ATHRAether Holdings Inc
US$ 5.5102
(-87.75%)
581.85k
TOROVToro Corporation
US$ 1.43
(-82.48%)
109.19k
LUCYInnovative Eyewear Inc
US$ 2.3471
(-52.58%)
1.95M
XHGXChange TED Inc
US$ 0.1985
(-45.71%)
8.09M
DMNDamon Inc
US$ 0.003
(-28.57%)
1.04B
BONBon Natural Life Ltd
US$ 0.066
(8.73%)
653.46M
STSSSharps Technology Inc
US$ 0.0245
(33.88%)
640.47M
NVDANVIDIA Corporation
US$ 110.93
(3.12%)
303.97M
LGMKLogicMark Inc
US$ 0.009699
(3.18%)
261.75M

CMPX Discussion

게시물 보기
glenn1919 glenn1919 2 주 전
CMPX..........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
green maschine green maschine 2 주 전
https://finance.yahoo.com/news/tovecimig-ctx-009-meets-primary-110000152.html

"We are thrilled to share these positive primary endpoint data from the COMPANION-002 study of tovecimig in patients with advanced biliary tract cancer," said Thomas Schuetz, MD, PhD, CEO of Compass and Vice Chairman of the Board of Directors. “We would like to thank all of the patients and their caregivers who have participated and continue to participate in this study. We believe these findings highlight the potential of tovecimig to provide a much-needed treatment option for the majority of patients with BTC who have limited alternatives after first-line therapy. We look forward to discussing these data with regulatory authorities."

“As a treating clinician for over 20 years, I have seen firsthand how challenging a disease biliary tract cancer is. Patients currently have very limited treatment options, with the vast majority in the second-line setting having no approved therapeutic alternative whatsoever. For every statistic there is a person – a mother, father, relative, or friend – fighting for more time. Each investigative trial helps in this fight to advance new treatment options, and I look forward to following tovecimig’s continued progress,” said Juan Valle, MD, Chief Medical Officer of the Cholangiocarcinoma Foundation.
👍️0
Bucks79 Bucks79 2 주 전
looks like we get the read out news in the AM .. and either it builds some really nice buying pressure... or its not great news and this thing dives. surprise this one is so quiet.
👍️0
Monksdream Monksdream 2 월 전
CMPX, new 52=week high
👍️0
Tiger Money Tiger Money 2 월 전
Man!  It has been some time!  You are one of the few money makers that I have met on ihub.  I always appreciate and laugh at your lack of tolerance for stupidity.  

Need your thoughts as I know u r more technical, but the fundamentals behind this name are scary good.  This low float could run massively (sound like 47) as they have cash until 2027 and about to potentially get some solid results from their phase 2/3 study. I have simply tripled my money waiting....
👍️0
TrendTrade2016 TrendTrade2016 2 월 전
CMPX bio beast breakout
👍️0
Tiger Money Tiger Money 2 월 전
Yep, seems like it makes a new 52 week high 3-4 times a week.  Someone must know something 
👍️0
Monksdream Monksdream 2 월 전
CMPX, new 52/high
👍️0
Tiger Money Tiger Money 2 월 전
What does this tell us?  Thanks 
👍️0
glenn1919 glenn1919 2 월 전
CMPX............................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 월 전
What does this tell you?  Thanks!
👍️0
glenn1919 glenn1919 3 월 전
CMPX...........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 월 전
the upcoming trials....apparently someone(s) may know the results?  The initial indication is that they were very good 
👍️0
Bucks79 Bucks79 3 월 전
broke out after consolidation.. don't see any news released?
👍️0
glenn1919 glenn1919 3 월 전
CMPX..............https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 3 월 전
listen to the webcasts and you will find mindblowing things every now and then. Like 6 out of 22 patients with 40% tumor decline in vegf dll4 monotherapy data.
And some people say theres a way to make the machine listen.
👍️0
Tiger Money Tiger Money 3 월 전
Someone must know something.... 
👍️0
Bucks79 Bucks79 3 월 전
a lot of action on this one in the last few days.
👍️0
glenn1919 glenn1919 3 월 전
CMPX........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 월 전
Gap filled 
👍️0
PonkenPlonken PonkenPlonken 3 월 전
and they didnt even speak about it today!
👍️0
Tiger Money Tiger Money 3 월 전
Some very good news out this morning!
👍️0
glenn1919 glenn1919 3 월 전
CMPX..................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 월 전
Thanks!
👍️0
glenn1919 glenn1919 3 월 전
sideways................higher lows.....possible breakout
👍️0
Tiger Money Tiger Money 3 월 전
What does your work tell you on this?  Thanks 
👍️0
glenn1919 glenn1919 3 월 전
cmpx.........................https://stockcharts.com/h-sc/ui?s=cmpxp=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 4 월 전
CMPX, under $2
👍️0
PonkenPlonken PonkenPlonken 4 월 전
Sorry for the late reply, your question got lost in the mailbox.
I believe 3-6$ isnt unreasonable if they publish a nice readout.

i believe a handful of patients showed more than 30% tumor shrinkage in vegf monotherapy data... I havent seen similar to date...... Nobody listens to webcasts anymore - they probably need an anaylst note to alert them LOL
VEGf space is full of scammers to... everyone jumped the train
👍 1
Tiger Money Tiger Money 5 월 전
If so, where do you think that puts the stock?  Thanks 
👍️0
PonkenPlonken PonkenPlonken 5 월 전
Wouldnt be surprised to see a partner announced in the 10q
👍️0
PonkenPlonken PonkenPlonken 5 월 전
boom coming never before monotherapy data in VEGF space.... a place flooded by bio grifters
👍️0
Monksdream Monksdream 6 월 전
CMPX under $2
👍️0
PonkenPlonken PonkenPlonken 6 월 전
high volume yesterday
👍️0
PonkenPlonken PonkenPlonken 7 월 전
EXCELLENT monotherapy data
VEGF targeted agents usually need the chemo combination to even get a signifcant response. They get it in monotherapy.
I think its going to run into the H1 2025 data.
👍️0
Monksdream Monksdream 7 월 전
CMPX under $2
👍️0
glenn1919 glenn1919 7 월 전
CMPX........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 8 월 전
CMPX....................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 월 전
CMPX under $2
👍️0
Monksdream Monksdream 1 년 전
CMPX 10Q due 3/25
👍️0
Monksdream Monksdream 1 년 전
CMPX 10Q due 3/18
👍️0
glenn1919 glenn1919 1 년 전
CMPX....................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 년 전
Cant say offhand
Read the latest 10Q
👍️0
stockweiser stockweiser 1 년 전
Do you know there current cash on hand?
👍️0
Monksdream Monksdream 1 년 전
CMPX 10Q due March 11
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52=week low
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52 week low
👍️0
Monksdream Monksdream 2 년 전
CMPX under $2
👍️0
Copilotdog Copilotdog 2 년 전
Solid company
👍️0
Mktman2024 Mktman2024 2 년 전
Compass to review latest phase 2 progress with CTX 009 and other items at ASCO Jan 19-21.
Company moving slowly into the spotlight.
👍️0